BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7923175)

  • 1. T cells from renal cell carcinoma patients exhibit an abnormal pattern of kappa B-specific DNA-binding activity: a preliminary report.
    Li X; Liu J; Park JK; Hamilton TA; Rayman P; Klein E; Edinger M; Tubbs R; Bukowski R; Finke J
    Cancer Res; 1994 Oct; 54(20):5424-9. PubMed ID: 7923175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.
    Bukowski RM; Rayman P; Uzzo R; Bloom T; Sandstrom K; Peereboom D; Olencki T; Budd GT; McLain D; Elson P; Novick A; Finke JH
    Clin Cancer Res; 1998 Oct; 4(10):2337-47. PubMed ID: 9796963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells.
    Wang W; Abbruzzese JL; Evans DB; Larry L; Cleary KR; Chiao PJ
    Clin Cancer Res; 1999 Jan; 5(1):119-27. PubMed ID: 9918209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in NF kappa B/Rel family proteins in splenic T-cells from tumor-bearing mice and reversal following therapy.
    Ghosh P; Sica A; Young HA; Ye J; Franco JL; Wiltrout RH; Longo DL; Rice NR; Komschlies KL
    Cancer Res; 1994 Jun; 54(11):2969-72. PubMed ID: 8187083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term inositol phosphate release, but not tyrosine kinase activity, correlates with IL-2 secretion and NF-AT induction in anti-CD3-activated peripheral human T lymphocytes.
    Bryan RG; Li Y; Totten RK; Van M; Tan TH; Rich RR
    Cell Immunol; 1994 Aug; 157(1):158-69. PubMed ID: 8039243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD30 ligation induces nuclear factor-kappa B activation in human T cell lines.
    McDonald PP; Cassatella MA; Bald A; Maggi E; Romagnani S; Gruss HJ; Pizzolo G
    Eur J Immunol; 1995 Oct; 25(10):2870-6. PubMed ID: 7589085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression.
    Wong HK; Kammer GM; Dennis G; Tsokos GC
    J Immunol; 1999 Aug; 163(3):1682-9. PubMed ID: 10415075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X; Kandasamy K; Srivastava RK
    Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle regulation of NF-kappa b-binding activity in cells from human glioblastomas.
    Ansari SA; Safak M; Del Valle L; Enam S; Amini S; Khalili K
    Exp Cell Res; 2001 May; 265(2):221-33. PubMed ID: 11302687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-10 inhibits nuclear factor-kappa B/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes.
    Romano MF; Lamberti A; Petrella A; Bisogni R; Tassone PF; Formisano S; Venuta S; Turco MC
    J Immunol; 1996 Mar; 156(6):2119-23. PubMed ID: 8690900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
    Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
    Cogswell PC; Guttridge DC; Funkhouser WK; Baldwin AS
    Oncogene; 2000 Feb; 19(9):1123-31. PubMed ID: 10713699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overproduction of NFKB2 (lyt-10) and c-Rel: a mechanism for HTLV-I Tax-mediated trans-activation via the NF-kappa B signalling pathway.
    Lanoix J; Lacoste J; Pepin N; Rice N; Hiscott J
    Oncogene; 1994 Mar; 9(3):841-52. PubMed ID: 8108127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related decreases in IL-2 production by human T cells are associated with impaired activation of nuclear transcriptional factors AP-1 and NF-AT.
    Whisler RL; Beiqing L; Chen M
    Cell Immunol; 1996 May; 169(2):185-95. PubMed ID: 8620546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
    Carrasco D; Rizzo CA; Dorfman K; Bravo R
    EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of NF-kappa B nuclear activity in peripheral blood mononuclear cells: role of CD28 antigen.
    Romano MF; Bisogni R; Lamberti A; Turco MC; Petrella A; Tassone P; Van Lier R; Formisano S; Venuta S
    Cell Immunol; 1994 Jul; 156(2):371-7. PubMed ID: 8025954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-induced sensitivity to apoptosis in T cells from patients with renal cell carcinoma: role of nuclear factor-kappaB suppression.
    Finke JH; Rayman P; George R; Tannenbaum CS; Kolenko V; Uzzo R; Novick AC; Bukowski RM
    Clin Cancer Res; 2001 Mar; 7(3 Suppl):940s-946s. PubMed ID: 11300495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of primary human T-lymphocytes through CD2 plus CD28 adhesion molecules induces long-term nuclear expression of NF-kappa B.
    Costello R; Lipcey C; Algarté M; Cerdan C; Baeuerle PA; Olive D; Imbert J
    Cell Growth Differ; 1993 Apr; 4(4):329-39. PubMed ID: 8098618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperation of binding sites for STAT6 and NF kappa B/rel in the IL-4-induced up-regulation of the human IgE germline promoter.
    Messner B; Stütz AM; Albrecht B; Peiritsch S; Woisetschläger M
    J Immunol; 1997 Oct; 159(7):3330-7. PubMed ID: 9317131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B.
    Kleinert H; Euchenhofer C; Ihrig-Biedert I; Förstermann U
    Mol Pharmacol; 1996 Jan; 49(1):15-21. PubMed ID: 8569701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.